The Innovation Center supports new and innovative companies that are focused on Healthcare Technologies and Medical Devices.
To date we are home to nine start-ups in the Southwest Riverside County area & house several resource organizations.
Murrieta Genomics is dedicated to finding those answers and advancing the use of genomic sequencing in precision medicine, agriculture, forensics, veterinary and direct to consumer applications by offering entrepreneurs access to the specialized equipment, know-how and mentors that can transform research into commercial enterprise.
SimplSeq has developed a proprietary process to prepare biological samples for next generation genomic sequencing processing that will save thousands of labs a great deal of time and expense. While the time and cost of the sequencing of DNA and RNA has dropped substantially, the process of extracting DNA or RNA from a biological sample, purifying it, and making enough copies to get a good read has basically remained the same.
GattaCo Inc. is a young Southern California startup company that develops solutions for the life science and medical industry.
GattaCo’s mission is to enable next generation diagnostics and simplified sample collection and processing. We do this by leveraging our patented Capillary Pressure Re-Set (or Cap-Reset™) Technology to create novel products and solutions for our partners.
Neyroblast GX's focus is to develop next-generation theranostic products for neurodegenerative and infectious diseases like Alzheimer’s disease and COVID-19. We also have a platform to provide custom-made human organoids and genetically engineered cells for screening drug, toxicity, and disease pathology. Our team of scientists comes from a range of backgrounds across academia, biotech, and pharma with extensive experience in nutraceutical biomedicine, genetics, neurobiology, drug development, and human stem cells.
Swellter is a patient immersion platform that is enriching the oncology patient-provider experience through consent, education, and data sharing in real-time. Swellter opens a window through which laboratory and pharmaceutical companies can share relevant and potentially transformative diagnostic and therapeutic options with oncologists and cancer patients. We are steadfast in building a transformative platform that will change the patient experience and engage all oncology stakeholders.
Markbotix is a highly promising assistive robotics startup that is reimagining independent living and accessibility. With a vision to enhance the quality of life for seniors and people with disabilities, and provide relief to caregivers, MARKBOTIX is developing cutting-edge robotic solutions that combine advanced technology with compassionate care. Their innovative robotic solution offers personalized assistance, mobility support, and companionship, transforming the way individuals with mobility challenges interact with their environment. Backed by a team of skilled engineers and industry experts, MARKBOTIX is poised to disrupt the market, making life accessible for all.
NeuroReality is a Dutch company that was founded in 2017 with the goal of 1) democratizing access to cognitive rehabilitation, 2) positively impacting the lives of millions of people around the world who suffer from cognitive impairments, and 3) helping reduce the global economic burden on society by lowering both the direct healthcare costs and the indirect costs of disability and lost productivity. Currently, the Company has a team of 10.
As of the end of 2022, Koji’s Quest, CE marked and patent pending, has run more than 15 pilot sites in The Netherlands, Belgium, Switzerland, and the United States. In 2023 the Company expects to expands its presence to the United States with the help of strategic distribution partners and its own Business Development and Sales team.
Experience the power of storytelling. AVA (Autism Sleep Tent) provides an immersive storytelling experience designed to engage your child's imagination, calm sensitivities, and help them settle into deep, restful sleep.
Macko Labs aims to minimize the systemic risks local communities face by decentralizing crucial infrastructure that they depend on. To achieve this, we develop or support innovative technologies that enable independence from centralized processes. We collaborate with partners to commercialize the resulting new products and services worldwide. With infrastructure and supply chains becoming more and more vulnerable to failure, Macko Labs will create a safer environment for communities to thrive in, one that is more secure and self-sufficient in a changing landscape.
Neuma Biotech is a medtech company incubated by the National University of Singapore (NUS), specializing in rapid breath tests for disease detection. Utilizing its proprietary human breath VOC database and data analysis algorithms, Breathonix has successfully demonstrated detection of COVID-19, early-stage lung cancer (stage 1 & 2), and misdiagnosed tuberculosis. With the ability to complete one breath test within a minute, Breathonix offers the fastest solution among its competitors.
The company's first commercial product, BreFence GO COVID-19 rapid breath test, launched in 2020 and obtained regulatory approval in multiple markets, showcasing superior throughput and accuracy. Apart from lung cancer, Breathonix's breath testing platform can also be applied to other cancers and respiratory diseases, offering a versatile and efficient diagnostic tool for various medical applications.
Super Family is a Dutch-rooted, innovative healthcare organization that focuses on social development, mental healthcare, educational support, development of new methods, research, and activities for families. Their target clients are mainly children with non-visible disabilities and Developmental Language Disorder (DLD). Super Family provides tailored healthcare support to families through a combination of their extensive specialized knowledge and traditional healthcare. Their mission is to prevent extensive relapse for children with DLD and to support the child’s development so they can reach their full potential. Super Family is committed to raising awareness of the prevalence of DLD so that children and families can get the right treatments and support with an innovative and hybrid approach.
Natea is composed of a multidisciplinary team of physicians, clinical informatics experts, analysts and managers who share a single vision: to provide Neonatology and Neonatal Intensive Care Unit, Pediatrics and Obstetrics departments with the most advanced software tools to help physicians and nurses during the patient care and assistance pathway allowing to reduce the associated clinical risk. Natea's goal is to improve and innovate the Information Systems of Neonatology, Pediatrics and Obstetrics, applying Machine Learning and Artificial Intelligence, in order to reduce clinical risk. The company's first commercial product, BreFence GO COVID-19 rapid breath test, launched in 2020 and obtained regulatory approval in multiple markets, showcasing superior throughput and accuracy. Apart from lung cancer, Breathonix's breath testing platform can also be applied to other cancers and respiratory diseases, offering a versatile and efficient diagnostic tool for various medical applications.
Under the agreement, the newly formed EPIC SBDC Resource Center will build on MIC’s current programming and business mentoring by leveraging the expertise of the EPIC SBDC’s pool of 15 entrepreneurs-in-residence (EIR) to provide hands-on consulting to tech-focused and scalable startups.
More Information Coming
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.